Evidence map›Paper›PMID 25437802›Full record

ArticlePathogens (Basel, Switzerland)2014

Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment.

Céline Lucchetti-Miganeh, David Redelberger, Gaël Chambonnier, François Rechenmann, Sylvie Elsen, Christophe Bordi, Katy Jeannot, Ina Attrée, Patrick Plésiat, Sophie de Bentzmann

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. High-riskHeliyon · 2025
    Article
  2. Article
  3. Article
  4. Carbapenem-ResistantMicroorganisms · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Céline Lucchetti-MiganehGenostar, 60 rue Lavoisier, Montbonnot 38330, France. miganeh@genostar.com.
David RedelbergerUMR7255-Laboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS-Aix Marseille University, Marseille 13402, France. redel@imm.cnrs.fr.
Gaël ChambonnierUMR7255-Laboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS-Aix Marseille University, Marseille 13402, France. gchambonnier@imm.cnrs.fr.
François RechenmannGenostar, 60 rue Lavoisier, Montbonnot 38330, France. rechenmann@genostar.com.
Sylvie ElsenINSERM, UMR-S 1036, Biology of Cancer and Infection, Grenoble 38054, France. sylvie.elsen@cea.fr.
Christophe BordiUMR7255-Laboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS-Aix Marseille University, Marseille 13402, France. bordi@imm.cnrs.fr.
Katy JeannotLaboratoire de Bactériologie, Faculté de Médecine-Pharmacie, Université de Franche-Comté, Besançon 25030, France. katy.jeannot@univ-fcomte.fr.
Ina AttréeINSERM, UMR-S 1036, Biology of Cancer and Infection, Grenoble 38054, France. ina.attree-delic@cea.fr.
Patrick PlésiatLaboratoire de Bactériologie, Faculté de Médecine-Pharmacie, Université de Franche-Comté, Besançon 25030, France. patrick.plesiat@univ-fcomte.fr.
Sophie de BentzmannUMR7255-Laboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS-Aix Marseille University, Marseille 13402, France. bentzman@imm.cnrs.fr.
Aix-Marseille Université · FRLaboratoire Microorganismes Génome et Environnement · FRUniversité de franche-comté · FRBiology of Infection · FRCentre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa is a Gram-negative environmental species and an opportunistic microorganism, establishing itself in vulnerable patients, such as those with cystic fibrosis (CF) or those hospitalized in intensive care units (ICU). It has become a major cause of nosocomial infections worldwide and a serious threat to Public Health because of overuse and misuse of antibiotics that have selected highly resistant strains against which very few therapeutic options exist. Herein is illustrated the intraclonal evolution of the genome of sequential isolates collected in a single CF patient from the early phase of pulmonary colonization to the fatal outcome. We also examined at the whole genome scale a pair of genotypically-related strains made of a drug susceptible, environmental isolate recovered from an ICU sink and of its multidrug resistant counterpart found to infect an ICU patient. Multiple genetic changes accumulated in the CF isolates over the disease time course including SNPs, deletion events and reduction of whole genome size. The strain isolated from the ICU patient displayed an increase in the genome size of 4.8% with major genetic rearrangements as compared to the initial environmental strain. The annotated genomes are given in free access in an interactive web application WallGene  designed to facilitate large-scale comparative analysis and thus allowing investigators to explore homologies and syntenies between P. aeruginosa strains, here PAO1 and the five clinical strains described.

Identifiers

PMID25437802
PMCPMC4243448
OpenAlexW2006652048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.